Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model.
about
Survival of encapsulated islets: More than a membrane storyHypoxia and Hypoxia-Inducible Factors in LeukemiasThe three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implicationsHypoxia and metabolic properties of hematopoietic stem cellsThe evolving role of the aryl hydrocarbon receptor (AHR) in the normophysiology of hematopoiesisOne more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent CellsModeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian modelsUse of Imaging Techniques to Illuminate Dynamics of Hematopoietic Stem Cells and Their NichesProtection of cells in physiological oxygen tensions against DNA damage-induced apoptosisHierarchy of breast cancer cells: key to reverse dormancy for therapeutic intervention.Culturing at atmospheric oxygen levels impacts lymphocyte functionEffects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells.The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.Numerical modeling of oxygen distributions in cortical and cancellous bone: oxygen availability governs osteonal and trabecular dimensions.Suppression of cytochrome p450 reductase enhances long-term hematopoietic stem cell repopulation efficiency in mice.Initial testing of the hypoxia-activated prodrug PR-104 by the pediatric preclinical testing program.Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cellsOxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.HIF targets in bone remodeling and metastatic disease.Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome?Prefabrication and free transfer of a tissue engineered composite flap - An experimental model in the rat.Benefits of hypoxic culture on bone marrow multipotent stromal cells.G protein-coupled receptors in haematopoietic disruption.p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced deathCancer stem cells and chemoresistance: The smartest survives the raidEnhanced growth of myelodysplastic colonies in hypoxic conditions(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversibleHypoxia and stem cell-based engineering of mesenchymal tissuesThe critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.Progressive Muscle Cell Delivery as a Solution for Volumetric Muscle Defect Repair.Direct measurement of local oxygen concentration in the bone marrow of live animals.The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization.Overcoming hypoxia to improve tissue-engineering approaches to regenerative medicine.CD133: holy of grail of neuro-oncology or promiscuous red-herring?Stem-cell niche based comparative analysis of chemical and nano-mechanical material properties impacting ex vivo expansion and differentiation of hematopoietic and mesenchymal stem cells.Hypoxia: how does the monocyte-macrophage system respond to changes in oxygen availability?Genetic and epigenetic instability of stem cells.
P2860
Q26751467-5034BE03-241A-41F0-8B8D-E2FB31CDF834Q26767167-E739E37E-BF9A-4191-878B-1FF21E330CB4Q26829663-225237B7-3AE4-4811-BD23-ECF3AC2FDA42Q26853702-ACD6D132-911F-41FB-90C2-5E31C2C26F6AQ27025264-6C8AC160-0510-4C7A-8215-FE421638F813Q27692583-B2A08669-10C8-4C79-B0F0-E92E911E8670Q28074203-F65413F4-530A-4716-AD23-8F07B8158682Q28344488-E262004C-E990-4333-A56B-44EBE47F567AQ33790004-051D47B5-A152-48D8-8B7F-0E06FCDE5F2FQ33810036-976F64A5-B3AD-46A8-8575-D424898557D3Q33816254-363AD99D-B507-4286-BC53-2ED79F57A0A5Q33928660-A1C924E7-9180-4D3E-922B-D2470516FD20Q34053889-2E24C016-8F94-49BF-85EE-431A08555449Q34134909-018AD10B-12D1-49EF-BD86-43676461A85DQ34304932-B507C4F9-1CF7-43AF-9F85-57A842544C73Q34904803-4BD55A30-E8C9-49E2-BAA7-55119937CBFAQ35005290-39D8B8BF-4A11-4283-85A9-B42D52FAE8C6Q35040064-83F41614-B71D-4678-B7D3-31D3348D4F5FQ35082752-8DE3DCB8-641D-4167-8BA0-1881F233BC71Q35486453-86E5E388-E295-4B63-A8E9-F2A409B5EA41Q35554344-8F978CAC-6C2E-46D3-B3C6-410601299518Q35779246-D9FED040-C4D0-44A4-ABC2-9B9004E5183BQ35945343-8D9A6922-85DF-4FA0-99C6-A768F2F79201Q36217409-9F24EB4C-2682-4ACB-85C4-C05218E5F97FQ36357726-069847A1-19F0-4DA8-BC72-F56C2247761BQ36377200-1E6A168B-25F1-4079-85E1-7DCF5CC111BAQ36445874-FB623C5A-E0F0-462B-AB86-048FCD0F7C66Q36730432-FD2A3CF7-FAF2-4A3B-AAD9-8F1BCD6C81C1Q36916269-A6DD5867-D1CE-430B-9550-C37C8761C36AQ37332185-2248ABA9-612B-438E-AADB-F0DF8FCA7228Q37386841-7E346BBE-B12A-4B32-98F8-552141120A93Q37413162-E1F1FFE3-8C10-4BCC-B29C-56B9275B9BEAQ37479577-C5A6E7BB-F228-4ABD-95EC-B58ED972F65DQ37698984-FA2A3651-21CF-4F3D-95B4-CA354B449F95Q37791426-80A66520-AC52-4FBA-A240-BE39F69CBB22Q38023826-8FB826A5-08F7-4F30-9E88-2BF8F215D6DAQ38056153-2B1657FF-55B9-422F-865F-C7CF52041904Q38062874-B474B8BC-B0A7-40CD-81A1-490B90F926F7Q38156255-5C980E86-FC13-4601-8CC8-6FB07A45FCE2Q38195438-5BBC9F7B-917C-4B42-9CD2-D32F7D7D84AB
P2860
Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modeling pO
@nl
Modeling pO(2) distributions i ...... compartment. I. Krogh's model.
@ast
Modeling pO(2) distributions i ...... compartment. I. Krogh's model.
@en
type
label
Modeling pO
@nl
Modeling pO(2) distributions i ...... compartment. I. Krogh's model.
@ast
Modeling pO(2) distributions i ...... compartment. I. Krogh's model.
@en
prefLabel
Modeling pO
@nl
Modeling pO(2) distributions i ...... compartment. I. Krogh's model.
@ast
Modeling pO(2) distributions i ...... compartment. I. Krogh's model.
@en
P2093
P2860
P1433
P1476
Modeling pO(2) distributions i ...... compartment. I. Krogh's model.
@en
P2093
E T Papoutsakis
L A Wenning
W M Miller
P2860
P304
P356
10.1016/S0006-3495(01)75732-3
P407
P577
2001-08-01T00:00:00Z